Blinatumomab for Treatment of Refractory Myasthenia Gravis
Clinical trial NCT06836973 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06836973
- Sponsor
- Da, Yuwei, M.D.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2028-03-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.